Eli Lilly and Company Profile (NYSE:LLY)

About Eli Lilly and

Eli Lilly and logoEli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, such as Humalog and Humalog Mix 75/25; neuroscience products, such as Cymbalta and Zyprexa; oncology products, such as Alimta and Cyramza, and cardiovascular products, such as Cialis and ReoPro. The Company's animal health products segment includes products for food animals, such as Rumensin and Posilac; products for companion animals, such as Onsior and Osurnia, and Novartis Animal Health (Novartis AH) products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LLY
  • CUSIP: 53245710
Key Metrics:
  • Previous Close: $78.01
  • 50 Day Moving Average: $80.76
  • 200 Day Moving Average: $76.06
  • Trailing P/E Ratio: 33.62
  • Foreward P/E Ratio: 19.07
  • P/E Growth: 1.67
  • Market Cap: $82.51B
  • Outstanding Shares: 1,057,699,000
  • Beta: 0.2
Additional Links:
Companies Related to Eli Lilly and:

Analyst Ratings

Consensus Ratings for Eli Lilly and (NYSE:LLY) (?)
Ratings Breakdown: 4 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $97.53 (25.02% upside)

Analysts' Ratings History for Eli Lilly and (NYSE:LLY)
Show:
DateFirmActionRatingPrice TargetDetails
8/13/2016Leerink SwannReiterated RatingOutperform$105.00View Rating Details
8/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
8/2/2016ArgusBoost Price TargetBuy$90.00 -> $95.00View Rating Details
7/27/2016BMO Capital MarketsReiterated RatingBuy$94.00View Rating Details
7/14/2016Jefferies GroupBoost Price TargetBuy$100.00 -> $105.00View Rating Details
7/6/2016Credit Suisse Group AGReiterated RatingBuy$91.00View Rating Details
6/15/2016SunTrust Banks Inc.Reiterated RatingBuyView Rating Details
6/4/2016Morgan StanleyReiterated RatingHold$88.00View Rating Details
4/6/2016Societe GeneraleInitiated CoverageHold$78.00View Rating Details
3/27/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
2/4/2016Berenberg BankBoost Price TargetBuy$105.00 -> $106.00View Rating Details
1/29/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$88.00 -> $86.00View Rating Details
1/29/2016Sanford C. BernsteinLower Price TargetOutperform$93.00 -> $92.00View Rating Details
12/22/2015Bank of America Corp.Reiterated RatingBuy$104.00 -> $108.00View Rating Details
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$100.00View Rating Details
12/9/2015Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
12/1/2015Barclays PLCUpgradeEqual Weight -> Overweight$75.00 -> $95.00View Rating Details
9/21/2015JPMorgan Chase & Co.Boost Price TargetNeutral$83.00 -> $90.00View Rating Details
8/21/2015Cowen and CompanyReiterated RatingOutperform$92.00View Rating Details
2/23/2015Tigress FinancialReiterated RatingBuyView Rating Details
10/2/2014GuggenheimInitiated CoverageBuy$80.00View Rating Details
9/15/2014MKM PartnersBoost Price TargetNeutral$61.00 -> $65.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Eli Lilly and (NYSE:LLY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
7/26/2016Q216$0.86$0.86$5.14 billion$5.40 billionViewListenView Earnings Details
4/26/2016Q116$0.85$0.83$4.82 billion$4.87 billionViewListenView Earnings Details
1/28/2016Q415$0.78$0.78$5.33 billion$5.38 billionViewListenView Earnings Details
10/22/2015Q315$0.76$0.89$4.99 billion$4.96 billionViewListenView Earnings Details
7/23/2015Q215$0.74$0.90$4.89 billion$4.98 billionViewListenView Earnings Details
4/23/2015Q115$0.76$0.87$4.62 billion$4.64 billionViewN/AView Earnings Details
1/30/2015Q414$0.74$0.75$5.21 billion$5.12 billionViewN/AView Earnings Details
10/23/2014Q314$0.67$0.66$4.83 billion$4.88 billionViewListenView Earnings Details
7/24/2014Q214$0.65$0.68$4.88 billion$4.94 billionViewN/AView Earnings Details
4/24/2014Q114$0.70$0.70$4.78 billion$4.68 billionViewN/AView Earnings Details
1/30/2014Q413$0.72$0.74$5.46 billion$5.81 billionViewListenView Earnings Details
10/23/2013Q313$1.04$1.11$5.76 billion$5.77 billionViewN/AView Earnings Details
7/24/2013Q2 2013$1.01$1.16$5.82 billion$5.93 billionViewN/AView Earnings Details
4/24/2013Q1 2013$1.05$1.14$5.66 billion$5.60 billionViewN/AView Earnings Details
1/29/2013Q4 2012$0.82$0.85$5.78 billion$5.96 billionViewN/AView Earnings Details
10/24/2012$0.82$0.79ViewN/AView Earnings Details
7/25/2012$0.76$0.83ViewN/AView Earnings Details
4/25/2012$0.80$0.92ViewN/AView Earnings Details
1/31/2012$0.80$0.87ViewN/AView Earnings Details
10/20/2011$1.12$1.13ViewN/AView Earnings Details
7/21/2011$1.18$1.18ViewN/AView Earnings Details
4/18/2011$1.16$1.24ViewN/AView Earnings Details
1/27/2011$1.10$1.11ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Eli Lilly and (NYSE:LLY)
Current Year EPS Consensus Estimate: $3.59 EPS
Next Year EPS Consensus Estimate: $4.09 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.80$0.86$0.83
Q2 20163$0.85$0.88$0.86
Q3 20162$0.90$0.92$0.91
Q4 20162$0.94$1.05$1.00
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Eli Lilly and (NYSE:LLY)
Annual Dividend:$2.04
Dividend Yield:2.62%
Payout Ratio:87.93% (Based on Trailing 12 Months of Earnings)
56.82% (Based on Current Year Consensus EPS Estimate)
49.88% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:0.70% (3 Year Average)

Dividend History for Eli Lilly and (NYSE:LLY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/20/2016quarterly$0.512.81%8/11/20168/15/20169/9/2016
5/2/2016quarterly$0.512.68%5/11/20165/13/20166/10/2016
12/8/2015quarterly$0.512.43%2/10/20162/12/20163/10/2016
10/19/2015quarterly$0.502.57%11/10/201511/13/201512/10/2015
6/15/2015quarterly$0.502.42%8/12/20158/14/20159/10/2015
5/4/2015quarterly$0.502.78%5/14/20155/18/20156/10/2015
12/15/2014quarterly$0.502.89%2/11/20152/13/20153/10/2015
10/20/2014quarterly$0.493.03%11/12/201411/14/201412/10/2014
6/16/2014quarterly$0.493.31%8/13/20148/15/20149/10/2014
5/5/2014quarterly$0.493.35%5/13/20145/15/20146/10/2014
12/16/2013quarterly$0.493.98%2/12/20142/14/20143/10/2014
10/21/2013quarterly$0.493.91%11/13/201311/15/201312/10/2013
6/18/2013quarterly$0.493.82%8/13/20138/15/20139/10/2013
5/6/2013quarterly$0.493.62%5/14/20135/16/20136/10/2013
12/17/2012quarterly$0.493.96%2/13/20132/15/20133/8/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Eli Lilly and (NYSE:LLY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Jackson P TaiDirectorBuy5,773$80.43$464,322.39View SEC Filing  
8/12/2016Jackson P TaiDirectorBuy2,560$80.42$205,875.20View SEC Filing  
7/29/2016Lilly Endowment IncMajor ShareholderSell205,000$82.94$17,002,700.00View SEC Filing  
7/28/2016Donald A ZakrowskiInsiderSell1,213$83.16$100,873.08View SEC Filing  
7/28/2016Lilly Endowment IncMajor ShareholderSell240,000$82.87$19,888,800.00View SEC Filing  
7/12/2016Lilly Endowment IncMajor ShareholderSell210,000$79.54$16,703,400.00View SEC Filing  
7/7/2016Lilly Endowment IncMajor ShareholderSell225,000$79.14$17,806,500.00View SEC Filing  
6/30/2016Lilly Endowment IncMajor ShareholderSell215,000$78.46$16,868,900.00View SEC Filing  
6/29/2016Lilly Endowment IncMajor ShareholderSell220,000$77.86$17,129,200.00View SEC Filing  
6/10/2016Melissa S BarnesSVPSell992$73.77$73,179.84View SEC Filing  
5/31/2016Lilly Endowment IncMajor ShareholderSell200,000$75.12$15,024,000.00View SEC Filing  
5/12/2016Jackson P TaiDirectorBuy1,080$75.75$81,810.00View SEC Filing  
5/12/2016Lilly Endowment IncMajor ShareholderSell190,000$75.86$14,413,400.00View SEC Filing  
5/2/2016Donald A ZakrowskiCAOSell1,600$75.86$121,376.00View SEC Filing  
4/29/2016Lilly Endowment IncMajor ShareholderSell180,000$75.44$13,579,200.00View SEC Filing  
4/27/2016Alfonso G ZuluetaSVPSell12,000$76.27$915,240.00View SEC Filing  
4/8/2016Lilly Endowment IncMajor ShareholderSell200,000$74.29$14,858,000.00View SEC Filing  
2/5/2016Stephen F FrySVPSell15,230$78.87$1,201,190.10View SEC Filing  
2/3/2016David A. RicksSVPSell5,733$77.66$445,224.78View SEC Filing  
2/3/2016Derica W. RiceCFOSell10,483$77.78$815,367.74View SEC Filing  
2/1/2016Jackson P TaiDirectorBuy3,170$78.62$249,225.40View SEC Filing  
1/29/2016Alfonso G ZuluetaSVPSell5,000$78.75$393,750.00View SEC Filing  
12/21/2015Lilly Endowment IncMajor ShareholderSell205,000$86.00$17,630,000.00View SEC Filing  
12/15/2015Lilly Endowment IncMajor ShareholderSell215,000$85.60$18,404,000.00View SEC Filing  
12/9/2015Enrique A ConternoVPSell25,000$83.88$2,097,000.00View SEC Filing  
12/2/2015Lilly Endowment Incmajor shareholderSell210,000$85.09$17,868,900.00View SEC Filing  
11/20/2015Lilly Endowment Incmajor shareholderSell205,000$84.54$17,330,700.00View SEC Filing  
10/29/2015Lilly Endowment Incmajor shareholderSell200,000$82.28$16,456,000.00View SEC Filing  
10/9/2015Lilly Endowment Incmajor shareholderSell215,000$85.86$18,459,900.00View SEC Filing  
10/5/2015Lilly Endowment Incmajor shareholderSell260,000$86.46$22,479,600.00View SEC Filing  
9/18/2015Lilly Endowment Incmajor shareholderSell250,000$89.04$22,260,000.00View SEC Filing  
6/10/2015Lilly Endowment IncMajor ShareholderSell210,000$82.39$17,301,900.00View SEC Filing  
6/4/2015Lilly Endowment IncMajor ShareholderSell200,000$77.90$15,580,000.00View SEC Filing  
5/29/2015Jeffrey N SimmonsSVPSell20,000$78.08$1,561,600.00View SEC Filing  
5/20/2015Lilly Endowment IncMajor ShareholderSell190,000$73.43$13,951,700.00View SEC Filing  
5/15/2015Lilly Endowment IncMajor ShareholderSell200,000$72.83$14,566,000.00View SEC Filing  
5/8/2015Lilly Endowment IncMajor ShareholderSell195,000$73.28$14,289,600.00View SEC Filing  
5/1/2015Lilly Endowment IncMajor ShareholderSell200,000$73.09$14,618,000.00View SEC Filing  
3/30/2015Lilly Endowment IncMajor ShareholderSell180,000$73.94$13,309,200.00View SEC Filing  
3/23/2015Lilly Endowment IncMajor ShareholderSell190,000$76.97$14,624,300.00View SEC Filing  
3/9/2015Stephen F FrySVPSell4,000$69.27$277,080.00View SEC Filing  
2/4/2015David A RicksSVPSell3,147$69.99$220,258.53View SEC Filing  
2/4/2015Derica W RiceCFOSell5,316$70.00$372,120.00View SEC Filing  
2/4/2015Jan M LundbergEVPSell11,085$70.08$776,836.80View SEC Filing  
2/3/2015Jan M LundbergEVPSell121,711$70.78$8,614,704.58View SEC Filing  
2/2/2015David A RicksSVPSell4,769$71.51$341,031.19View SEC Filing  
2/2/2015Derica W RiceCFOSell10,068$71.84$723,285.12View SEC Filing  
12/4/2014Lilly Endowment IncMajor ShareholderSell190,000$71.92$13,664,800.00View SEC Filing  
12/2/2014Lilly Endowment IncMajor ShareholderSell180,000$70.14$12,625,200.00View SEC Filing  
11/13/2014Lilly Endowment IncMajor ShareholderSell200,000$67.73$13,546,000.00View SEC Filing  
11/5/2014Lilly Endowment IncMajor ShareholderSell180,000$67.00$12,060,000.00View SEC Filing  
11/4/2014Fionnuala M WalshSVPSell15,000$67.00$1,005,000.00View SEC Filing  
11/3/2014Enrique A ConternoVPSell5,000$66.03$330,150.00View SEC Filing  
10/31/2014Fionnuala M WalshSVPSell7,376$66.58$491,094.08View SEC Filing  
10/31/2014Lilly Endowment IncMajor ShareholderSell190,000$66.40$12,616,000.00View SEC Filing  
10/30/2014Lilly Endowment IncMajor ShareholderSell175,000$66.58$11,651,500.00View SEC Filing  
10/24/2014Maria A CroweInsiderSell2,750$65.77$180,867.50View SEC Filing  
10/6/2014Lilly Endowment IncMajor ShareholderSell210,000$65.63$13,782,300.00View SEC Filing  
10/1/2014Enrique A ConternoVPSell5,000$64.86$324,300.00View SEC Filing  
9/30/2014Lilly Endowment IncMajor ShareholderSell200,000$65.07$13,014,000.00View SEC Filing  
9/10/2014Lilly Endowment IncMajor ShareholderSell210,000$64.77$13,601,700.00View SEC Filing  
9/3/2014Lilly Endowment IncMajor ShareholderSell200,000$63.99$12,798,000.00View SEC Filing  
9/2/2014Enrique A ConternoVPSell5,000$63.60$318,000.00View SEC Filing  
7/29/2014Lilly Endowment IncMajor ShareholderSell250,000$63.03$15,757,500.00View SEC Filing  
7/28/2014Susan MahonySVPSell2,065$63.30$130,714.50View SEC Filing  
7/25/2014Enrique A ConternoVPSell10,000$63.79$637,900.00View SEC Filing  
7/25/2014Susan MahonySVPSell30,000$63.90$1,917,000.00View SEC Filing  
7/1/2014Lilly Endowment IncMajor ShareholderSell235,000$62.30$14,640,500.00View SEC Filing  
6/25/2014Lilly Endowment IncMajor ShareholderSell245,000$62.68$15,356,600.00View SEC Filing  
6/20/2014Lilly Endowment IncMajor ShareholderSell230,000$61.55$14,156,500.00View SEC Filing  
6/16/2014Lilly Endowment IncMajor ShareholderSell200,000$58.73$11,746,000.00View SEC Filing  
6/5/2014Lilly Endowment IncMajor ShareholderSell190,000$59.53$11,310,700.00View SEC Filing  
5/21/2014Lilly Endowment Incmajor shareholderSell230,000$58.90$13,547,000.00View SEC Filing  
5/12/2014Jackson TaiDirectorBuy17,157$59.19$1,015,522.83View SEC Filing  
5/12/2014Lilly Endowment Incmajor shareholderSell210,000$59.33$12,459,300.00View SEC Filing  
5/6/2014Lilly Endowment Incmajor shareholderSell190,000$58.79$11,170,100.00View SEC Filing  
4/29/2014Lilly Endowment Incmajor shareholderSell200,000$59.43$11,886,000.00View SEC Filing  
4/28/2014Lilly Endowment Incmajor shareholderSell150,000$58.64$8,796,000.00View SEC Filing  
8/15/2013Enrique ConternoVPSell5,000$53.79$268,950.00View SEC Filing  
7/29/2013Jacques TapieroSVPSell7,500$53.74$403,050.00View SEC Filing  
7/15/2013Enrique A ConternoVPSell5,000$51.43$257,150.00View SEC Filing  
6/17/2013Enrique A ConternoVPSell5,000$52.45$262,250.00View SEC Filing  
5/15/2013Enrique A ConternoVPSell5,000$56.15$280,750.00View SEC Filing  
5/10/2013Jeffrey N SimmonsSVPSell10,000$54.49$544,900.00View SEC Filing  
3/26/2013Susan MahonySVPSell5,000$56.00$280,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Eli Lilly and (NYSE:LLY)
DateHeadline
News IconEli Lilly & Company (NYSE:LLY) Sellers Increased By 0.06% Their Shorts (NYSE:LLY)
magseriesusa.net - August 25 at 5:57 PM
News IconEli Lilly faces tough times with patent losses (NYSE:LLY)
health.asiaone.com - August 25 at 5:57 PM
News IconLeading stocks in today’s market: Eli Lilly and Company (NYSE:LLY) (NYSE:LLY)
twincountynews.com - August 25 at 5:57 PM
News IconHot Stock's Alert: Eli Lilly and Co (NYSE:LLY), Zoetis Inc (NYSE:ZTS) - NYSE Journal (press release) (NYSE:LLY)
stockznews.com - August 25 at 11:02 AM
News IconNews Recap - GoPro (NASDAQ:GPRO), Eli Lilly and Co (NYSE:LLY) - Money News (press release) (NYSE:LLY)
www.newsismoney.com - August 25 at 11:02 AM
capitalcube.com logoEli Lilly & Co. breached its 50 day moving average in a Bearish Manner : LLY-US : August 25, 2016 (NYSE:LLY)
www.capitalcube.com - August 25 at 11:01 AM
finance.yahoo.com logoLilly to Participate in Morgan Stanley Global Healthcare Conference (NYSE:LLY)
finance.yahoo.com - August 24 at 5:49 PM
publicnow.com logoAcrux and Eli Lilly to appeal patent ruling on Axiron (NYSE:LLY)
www.publicnow.com - August 24 at 9:02 AM
marketrealist.com logoWhy AstraZeneca Reported Negative Growth in 2Q16 (NYSE:LLY)
marketrealist.com - August 23 at 6:09 PM
News IconTraders Alert - Regions Financial (NYSE:RF), Eli Lilly and Co (NYSE:LLY) - Money News (press release) (NYSE:LLY)
www.newsismoney.com - August 23 at 10:24 AM
News IconEli Lilly's next CEO could carry first Alzheimer's treatment across the finish line - Indianapolis Star (NYSE:LLY)
www.indystar.com - August 23 at 10:24 AM
streetinsider.com logoEli Lilly & Co. (LLY), AstraZeneca (AZN) Receive FDA Fast Track Designation for AZD3293 as BACE Inhibitor - StreetInsider.com (NYSE:LLY)
www.streetinsider.com - August 23 at 10:24 AM
finance.yahoo.com logoFundstrat's high-yield picks (NYSE:LLY)
finance.yahoo.com - August 23 at 10:24 AM
finance.yahoo.com logoEli Lilly, AstraZeneca Alzheimer's Drug Gets FDA Fast Track (NYSE:LLY)
finance.yahoo.com - August 23 at 10:24 AM
News IconAstraZeneca share price: Group and Lilly’s Alzheimer’s treatment fast-tracked (NYSE:LLY)
invezz.com - August 22 at 6:00 PM
News IconLilly drug for Alzheimer's gets fast-tracked by FDA (NYSE:LLY)
www.ibj.com - August 22 at 6:00 PM
marketrealist.com logoHow Did Novo’s Diabetes and Obesity Care Segment Perform in 1H16? (NYSE:LLY)
marketrealist.com - August 22 at 6:00 PM
marketrealist.com logoWhy Did Novo’s Valuation Multiple Fall Recently? (NYSE:LLY)
marketrealist.com - August 22 at 6:00 PM
seekingalpha.com logoLilly and AstraZeneca's AZD3293 Fast Track'd for early Alzheimer's (NYSE:LLY)
seekingalpha.com - August 22 at 10:32 AM
morningstar.co.uk logoAstraZeneca, Eli Lilly Get Fast Track Designation For AZD3239 (NYSE:LLY)
www.morningstar.co.uk - August 22 at 10:32 AM
investors.com logoAstraZeneca's Alzheimer's drug fast-tracked by FDA (NYSE:LLY)
www.proactiveinvestors.com - August 22 at 10:32 AM
rttnews.com logoEli Lilly, AstraZeneca Get Fast Track Designation For AZD3293 (NYSE:LLY)
www.rttnews.com - August 22 at 10:32 AM
streetinsider.com logoEli Lilly & Co. (LLY), AstraZeneca (AZN) Receive FDA Fast Track Designation for AZD3293 as BACE Inhibitor (NYSE:LLY)
www.streetinsider.com - August 22 at 10:32 AM
marketwatch.com logoEli Lilly, AstraZeneca drug put on FDA fast track (NYSE:LLY)
www.marketwatch.com - August 22 at 10:32 AM
marketrealist.com logoHow Did Bristol-Myers Squibb’s Oncology Segment Perform in 2Q16? (NYSE:LLY)
marketrealist.com - August 22 at 10:32 AM
News IconEli Lilly's next CEO could carry first Alzheimer's treatment across the finish line (NYSE:LLY)
www.indystar.com - August 21 at 10:14 AM
News IconDrug Manufacturers – Major: Eli Lilly and Company (NYSE:LLY) Position of the day (NYSE:LLY)
twincountynews.com - August 19 at 5:55 PM
News IconNo Pain, Potential for Lots of Gain (NYSE:LLY)
news.morningstar.com - August 19 at 8:58 AM
4-traders.com logoEli Lilly and : Lilly Provides Update on MONARCH 2 Phase 3 Trial of Abemaciclib (NYSE:LLY)
www.4-traders.com - August 18 at 6:00 PM
News IconHC Stocks Alerts: Anthem Inc (NYSE:ANTM), Eli Lilly and Co (NYSE:LLY) - share market updates (press release) (NYSE:LLY)
sharemarketupdates.com - August 18 at 9:00 AM
News IconBetter Buy: AbbVie Inc. vs. Eli Lilly & Co. - Madison.com (NYSE:LLY)
host.madison.com - August 18 at 9:00 AM
News IconLarge Cap Drug Manufacturers – Major: Eli Lilly and Company (NYSE:LLY) (NYSE:LLY)
twincountynews.com - August 17 at 6:09 PM
News IconTop Gainers of the Day: Eli Lilly and Company (NYSE:LLY) from Drug Manufacturers – Major (NYSE:LLY)
twincountynews.com - August 17 at 9:00 AM
sbwire.com logoGlobal Depressive Disorder Market Companies (Pfizer, AstraZeneca, Eli Lilly and Company, and Lundbeck) Analysis & Forecast 2016-2020 (NYSE:LLY)
www.sbwire.com - August 16 at 6:04 PM
News IconEli Lilly’s Take on Building a High-Performance Culture Through Narratives (NYSE:LLY)
insights.ethisphere.com - August 16 at 6:04 PM
News IconGifts Roundup: Eli Lilly CEO Gives $5 Million to Central Indiana United Way (NYSE:LLY)
www.philanthropy.com - August 15 at 6:09 PM
News IconMayor Hogsett, Eli Lilly CEO unveil push for statewide Pre-K (NYSE:LLY)
wishtv.com - August 13 at 8:54 AM
News IconStocks in Focus: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Eli Lilly and Co(NYSE:LLY) - NYSE Journal (press release) (NYSE:LLY)
stockznews.com - August 12 at 6:03 PM
News IconHilton Worldwide Holdings (NYSE:HLT) & Eli Lilly and Co (NYSE:LLY) Notable Runners - Money News (press release) (NYSE:LLY)
www.newsismoney.com - August 12 at 6:03 PM
marketrealist.com logoIs Merck’s Valuation Improving? (NYSE:LLY)
marketrealist.com - August 12 at 6:03 PM
News IconMayor Hogsett, Eli Lilly CEO set to unveil push for statewide Pre-K - WISH-TV (NYSE:LLY)
wishtv.com - August 12 at 9:10 AM
wsj.com logoEli Lilly's Investigational Cancer Drug Hits Snag in Breast Cancer Trial - Wall Street Journal (NYSE:LLY)
www.wsj.com - August 12 at 9:10 AM
marketexclusive.com logoEli Lilly And Co (NYSE:LLY) Abemaciclib Fails Efficacy Criteria, Giving Pfizer Inc. (NYSE:PFE) Ibrance A Significant ... - Market Exclusive (NYSE:LLY)
marketexclusive.com - August 12 at 9:10 AM
streetinsider.com logoEli Lilly & Co. (LLY) Names New Finance SVP (NYSE:LLY)
www.streetinsider.com - August 11 at 6:14 PM
News IconLechleiter, Lilly Foundation give $10 million to United Way (NYSE:LLY)
www.ibj.com - August 11 at 6:14 PM
News IconRetiring Lilly CEO donates $5M to United Way for pre-K (NYSE:LLY)
www.indystar.com - August 11 at 6:14 PM
marketexclusive.com logoEli Lilly And Co (NYSE:LLY) Abemaciclib Fails Efficacy Criteria, Giving Pfizer Inc. (NYSE:PFE) Ibrance A Significant Lead (NYSE:LLY)
marketexclusive.com - August 11 at 6:14 PM
finance.yahoo.com logoElanco Launches New Video Series Illustrating the Powerful Bond Between Service Dogs, Owners (NYSE:LLY)
finance.yahoo.com - August 11 at 9:04 AM
schaeffersresearch.com logoBuzz Stocks: Eli Lilly and Co, Myriad Genetics, Inc., and Perrigo Company plc - Schaeffers Research (blog) (NYSE:LLY)
www.schaeffersresearch.com - August 10 at 6:19 PM
bidnessetc.com logoIndependent Panel Finds Eli Lilly and Co Unable to Launch Breast Cancer Molecule - Bidness ETC (NYSE:LLY)
www.bidnessetc.com - August 10 at 6:19 PM

Social

Eli Lilly and (NYSE:LLY) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff